Dr. Reddy's Laboratories balance sheet

As of Sep 2026

Total assets: ₹57,631cr+6.0% on Sep 2025
Shareholders' equity: ₹39,126cr+7.6% on Sep 2025
Total debt: ₹5,826cr+29.6% on Sep 2025
Cash and investments: ₹4,611cr−6.1% on Sep 2025

₹ crore except per share

Tap a line for its trend	H1 FY27Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	10,269	10,078	7,298	6,249	5,654
	1,207	1,460	2,399	1,351	975
	1,488	1,480	1,314	550	547
	10,417	10,506	9,614	3,627	3,018
	0.0	0.0	66.2	68.3	54.9
	587	567	481	420	470
	634	894	239	106	66.0
	528	292	888	121	72.7
	1,162	1,186	1,127	227	139
	2,290	2,219	1,833	1,058	705
	480	448	276	509	27.6
	27,899	27,944	24,409	14,059	11,591
	8,118	7,653	7,109	6,355	4,867
	3,282	3,823	3,331	4,405	4,450
	10,140	10,123	9,042	8,030	7,249
	1,329	1,537	1,465	711	578
	2,263	1,812	995	1,017	1,152
	1,156	2,241	370	2,270	618
	18,170	19,536	15,203	16,432	14,047
	3,444	2,990	2,707	2,018	1,512
	29,732	30,179	25,018	24,805	20,694
	57,631	58,123	49,427	38,864	32,285
Equity
	83.5	83.5	83.4	83.4	83.3
	38,724	37,808	33,466	28,171	23,203
	38,807	37,892	33,550	28,255	23,286
	319	339	378	0.0	—
	39,126	38,231	33,927	28,255	23,286
Liabilities
	0.0	0.0	380	380	128
	1,192	1,264	426	219	—
	1,192	1,264	806	599	128
	35.6	33.8	29.8	23.9	19.9
	1,608	1,547	1,404	84.1	76.0
	240	301	226	314	203
	3,075	3,145	2,465	1,021	427
	5,826	6,294	3,805	1,272	1,219
	3,236	3,038	2,648	2,614	2,268
	4,179	4,919	4,184	3,632	2,931
	13,241	14,250	10,636	7,518	6,419
	833	870	776	692	653
	285	435	303	234	214
	1,072	1,192	1,319	1,144	1,286
	15,430	16,747	13,034	9,588	8,572
	18,505	19,893	15,499	10,609	8,999
	57,631	58,123	49,427	38,864	32,285
Assets — additional as-filed lines
	0.0	0.0	0.0	—	269
Trade payables — MSME split
	34.9	33.4	21.0	28.2	8.3
	3,201	3,005	2,627	2,586	2,260

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

DRREDDY₹1,335.40

Dr. Reddy's Laboratories Ltd.

· Pharma & Health

₹ CrorePeersSUNPHARMA CIPLA LUPIN APOLLOHOSP MAXHEALTH DIVISLAB TORNTPHARM ZYDUSLIFEMcap ₹1.12L Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	5,654.2	6,248.7	7,298.4	10,077.8	10,269.0
+ Capital Work-in-Progress	975.2	1,351.0	2,399.4	1,460.2	1,206.7
+ Goodwill	547.4	550.1	1,313.9	1,479.7	1,487.7
+ Other Intangibles	3,017.5	3,626.8	9,614.1	10,505.8	10,416.5
+ Intangibles under Development	54.9	68.3	66.2	0.0	0.0
+ Investments (Equity Method)	470.2	419.6	481.1	567.3	586.7
+ Non-current Investments	66.0	105.9	239.3	894.2	634.1
+ Other Non-current Financial Assets	72.7	121.2	887.5	291.7	528.1
Non-current Financial Assets	138.7	227.1	1,126.8	1,185.9	1,162.2
+ Deferred Tax Assets	705.2	1,057.8	1,832.5	2,219.0	2,290.4
+ Other Non-current Assets	27.6	509.1	276.1	448.4	479.9
Total Non-current Assets	11,590.9	14,058.5	24,408.5	27,944.1	27,899.1
Current Assets
+ Inventories	4,867.0	6,355.2	7,108.5	7,653.4	8,118.2
+ Current Investments	4,449.6	4,405.0	3,330.7	3,823.3	3,281.6
+ Trade Receivables	7,248.5	8,029.8	9,042.0	10,123.4	10,139.9
+ Cash & Cash Equivalents	577.9	710.7	1,465.4	1,536.8	1,329.4
+ Other Bank Balances	1,152.3	1,017.0	994.8	1,811.9	2,263.2
+ Other Current Financial Assets	618.2	2,269.6	369.9	2,241.0	1,155.5
Current Financial Assets	14,046.5	16,432.1	15,202.8	19,536.4	18,169.6
+ Other Current Assets	1,512.0	2,018.0	2,706.8	2,989.5	3,444.4
Total Current Assets	20,694.2	24,805.3	25,018.1	30,179.3	29,732.2
Total Assets	32,285.1	38,863.8	49,426.6	58,123.4	57,631.3
Equity
+ Equity Share Capital	83.3	83.4	83.4	83.5	83.5
+ Other Equity / Reserves	23,202.8	28,171.4	33,466.2	37,808.0	38,723.5
Equity — Owners of Parent	23,286.1	28,254.8	33,549.6	37,891.5	38,807.0
+ Minority Interest	—	0.0	377.8	339.4	319.1
Total Equity	23,286.1	28,254.8	33,927.4	38,230.9	39,126.1
Liabilities
+ Borrowings — Non-current	127.8	380.0	380.0	0.0	0.0
+ Other Non-current Financial Liab	—	219.0	426.2	1,263.5	1,191.9
Non-current Financial Liabilities	127.8	599.0	806.2	1,263.5	1,191.9
+ Provisions — Non-current	19.9	23.9	29.8	33.8	35.6
+ Deferred Tax Liabilities	76.0	84.1	1,403.8	1,546.7	1,607.9
+ Other Non-current Liabilities	203.2	314.0	225.6	301.1	239.5
Non-current Liabilities	426.9	1,021.0	2,465.4	3,145.1	3,074.9
+ Borrowings — Current	1,219.4	1,272.3	3,804.5	6,293.5	5,826.0
+ Trade Payables	2,268.4	2,614.4	2,647.8	3,037.9	3,236.3
+ Other Current Financial Liab	2,931.2	3,631.5	4,184.1	4,918.6	4,178.9
Current Financial Liabilities	6,419.0	7,518.2	10,636.4	14,250.0	13,241.2
+ Provisions — Current	652.5	692.0	775.6	870.0	832.9
+ Current Tax Liabilities	214.3	234.1	302.8	435.3	284.7
+ Other Current Liabilities	1,286.3	1,143.7	1,319.0	1,192.1	1,071.5
Current Liabilities	8,572.1	9,588.0	13,033.8	16,747.4	15,430.3
Total Liabilities	8,999.0	10,609.0	15,499.2	19,892.5	18,505.2
Total Equity & Liabilities	32,285.1	38,863.8	49,426.6	58,123.4	57,631.3
Assets — additional as-filed lines
+ Current Tax Assets	268.7	—	0.0	0.0	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	8.3	28.2	21.0	33.4	34.9
+ Dues to Other Creditors — Current	2,260.1	2,586.2	2,626.8	3,004.5	3,201.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.